GALWAY, IRELAND--November 23, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The European Commission (EC) has signed a deal for up to 300 million doses of BioNTech-Pfizer's COVID-19 vaccine just weeks after the partners' claimed that early test results found it to be more than 90% effective.

Within this article: Details deal for COVID-19 potential vaccine, partners involved, manufacturing plants, capacities and timelines